Company type | Private |
---|---|
Industry | Biotechnology |
Headquarters | , |
Stem Cell Theranostics is a privately held biotech company based out of Redwood City, California that provides drug companies with a method to more accurately predict cardiotoxicity and cardiovascular drug efficacy. [1]
Stem Cell Theranostics was one of the first med tech startup to come out of the StartX incubator program. The company uses technology developed at Stanford, [2] [3] to create a "clinical trial in a dish" drug screening platform, which reduces the risk of drug development. [4] The company currently works with drug discovery and biotechnology companies to use patient-specific induced pluripotent stem cells for development of novel therapeutics. [5]